Saccharin, acting as a weak acid, forms salts with basic APIs and these salts have the desirable property of enhanced water solubility
The search for new solid forms of an active pharmaceutical ingredient (API) is an important step in ...
The crystallisation of an active pharmaceutical ingredient (API) is a fundamental step in the manufa...
Active Pharmaceutical Ingredients (API) crystallized in its co-crystal form is believed to be able t...
Saccharin, acting as a weak acid, forms salts with basic APIs and these salts have the desirable pro...
Salts of active pharmaceutical ingredients (APIs) have been traditionally used in drug formulations ...
Synthon robustness or lack of structural interference is a sought after goal in crystal engineering....
Co-crystallization alters the molecular interactions and composition of pharmaceutical materials, an...
ABSTRACT Pharmaceutical materials science being a fundamental branch that continuously provides impo...
Crystal form (cocrystals, polymorphs, salts, hydrates and solvates) assortment remains a scientific ...
Solubility enhancement of poorly-soluble active pharmaceutical ingredients (APIs) remains a scientif...
Most drugs are formulated, when possible, as salts, for their better technological parameters, such ...
The salt formation of an active pharmaceutical ingredient (API) changes some physical and chemical p...
Objective: The aim of this study was to develop a solid dosage form of glibenclamide with increasing...
ABSTRACT: Co-crystals consists of API and a stoichiometric amount of a pharmaceutically acceptable c...
Communication presented at the 12th Annual Symposium, Pharmaceutical Solid State Research Cluster (P...
The search for new solid forms of an active pharmaceutical ingredient (API) is an important step in ...
The crystallisation of an active pharmaceutical ingredient (API) is a fundamental step in the manufa...
Active Pharmaceutical Ingredients (API) crystallized in its co-crystal form is believed to be able t...
Saccharin, acting as a weak acid, forms salts with basic APIs and these salts have the desirable pro...
Salts of active pharmaceutical ingredients (APIs) have been traditionally used in drug formulations ...
Synthon robustness or lack of structural interference is a sought after goal in crystal engineering....
Co-crystallization alters the molecular interactions and composition of pharmaceutical materials, an...
ABSTRACT Pharmaceutical materials science being a fundamental branch that continuously provides impo...
Crystal form (cocrystals, polymorphs, salts, hydrates and solvates) assortment remains a scientific ...
Solubility enhancement of poorly-soluble active pharmaceutical ingredients (APIs) remains a scientif...
Most drugs are formulated, when possible, as salts, for their better technological parameters, such ...
The salt formation of an active pharmaceutical ingredient (API) changes some physical and chemical p...
Objective: The aim of this study was to develop a solid dosage form of glibenclamide with increasing...
ABSTRACT: Co-crystals consists of API and a stoichiometric amount of a pharmaceutically acceptable c...
Communication presented at the 12th Annual Symposium, Pharmaceutical Solid State Research Cluster (P...
The search for new solid forms of an active pharmaceutical ingredient (API) is an important step in ...
The crystallisation of an active pharmaceutical ingredient (API) is a fundamental step in the manufa...
Active Pharmaceutical Ingredients (API) crystallized in its co-crystal form is believed to be able t...
DOI
Add to ORKG